Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder
No abstract is available for this record.
Bibliographic context
- Journal
- Neuroscience Applied
- Date
- 2021-12-31
- Source
- OpenAlex
- PubMed
- Unavailable
Authors
Nathalie M. RieserLadina P GubserC. Rossgoderer Da SilvaFranz X. VollenweiderMarcus HerdenerKatrin H. Preller
Watch author
Topics and keywords
psilocybin AddictionBiomarkers Other PsilocybinCue reactivityBiomarkerAlcohol use disorderReactivity (psychology)PsychologyAlcoholPsychotherapistCocaine usePsychiatryMedicineHallucinogenAddictionCravingChemistryAlternative medicinePathologyBiochemistryPsychedelics and Drug StudiesMental Health Research Topics
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”Journal of Affective Disorders · 2025-11-10An open-label pilot study of psilocybin-assisted therapy for binge eating disorderJournal of Eating Disorders · 2026-01-02Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapyJournal of Affective Disorders · 2025-12-16Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosaJournal of Eating Disorders · 2025-05-25Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit postsJournal of Affective Disorders · 2026-01-19Questioning the recovery of dissociated traumatic memories under psilocybin: comment on “Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa”Journal of Eating Disorders · 2025-12-03Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey studyJournal of Affective Disorders · 2024-10-21Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot studyJournal of Affective Disorders · 2024-09-26